Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic Device.

Biosensors (Basel)

Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

Published: February 2024

AI Article Synopsis

  • Countries are increasingly decriminalizing or legalizing cannabis for recreational and medical use, with cannabinoids affecting various bodily functions and potentially posing public safety risks.
  • There is a growing interest in developing rapid, accurate methods for detecting cannabinoids in oral fluid, which can show recent use compared to urine tests that indicate past consumption.
  • Recent advancements focus on improving sensitivity and user-friendliness of analytical technologies for cannabinoid detection, emphasizing the role of oral fluid in point-of-care diagnostics.

Article Abstract

An increasing number of countries have started to decriminalize or legalize the consumption of cannabis for recreational and medical purposes. The active ingredients in cannabis, termed cannabinoids, affect multiple functions in the human body, including coordination, motor skills, memory, response time to external stimuli, and even judgment. Cannabinoids are a unique class of terpeno-phenolic compounds, with 120 molecules discovered so far. There are certain situations when people under the influence of cannabis may be a risk to themselves or the public safety. Over the past two decades, there has been a growing research interest in detecting cannabinoids from various biological matrices. There is a need to develop a rapid, accurate, and reliable method of detecting cannabinoids in oral fluid as it can reveal the recent intake in comparison with urine specimens, which only show a history of consumption. Significant improvements are continuously made in the analytical formats of various technologies, mainly concerning improving their sensitivity, miniaturization, and making them more user-friendly. Additionally, sample collection and pretreatment have been extensively studied, and specific devices for collecting oral fluid specimens have been perfected to allow rapid and effective sample collection. This review presents the recent findings regarding the use of oral fluid specimens as the preferred biological matrix for cannabinoid detection in a point-of-care biosensor diagnostic device. A critical review is presented, discussing the findings from a collection of review and research articles, as well as publicly available data from companies that manufacture oral fluid screening devices. Firstly, the various conventional methods used to detect cannabinoids in biological matrices are presented. Secondly, the detection of cannabinoids using point-of-care biosensors is discussed, emphasizing oral fluid specimens. This review presents the current pressing technological challenges and highlights the gaps where new technological solutions can be implemented.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10968443PMC
http://dx.doi.org/10.3390/bios14030126DOI Listing

Publication Analysis

Top Keywords

oral fluid
24
fluid specimens
16
detection cannabinoids
8
cannabinoids oral
8
specimens preferred
8
preferred biological
8
biological matrix
8
point-of-care biosensor
8
biosensor diagnostic
8
diagnostic device
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!